A detailed history of Cibc Private Wealth Group, LLC transactions in Pulmonx Corp stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 5,000 shares of LUNG stock, worth $38,550. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,000
Previous 5,000 -0.0%
Holding current value
$38,550
Previous $46,000 32.61%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$8.71 - $14.65 $43,550 - $73,250
5,000 New
5,000 $46,000
Q1 2021

May 12, 2021

SELL
$44.0 - $67.54 $176,000 - $270,160
-4,000 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$39.31 - $69.02 $157,240 - $276,080
4,000 New
4,000 $276,000

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $287M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.